Vidaza (correction)
Executive Summary
Pharmion licensed full development and commercialization rights for Vidaza (azacitidine) from Pharmacia in 2001 (1"The Pink Sheet" Sept. 1, 2003, p. 24). A March 7 2story on MGI's Dacogen, inaccurately said Pharmion copromotes Vidaza with Pfizer. Vidaza, which cleared FDA in May 2004, is the only product approved for treatment of MDS...